| Name | Title | Contact Details |
|---|
Affinity Biologicals Inc. is a Ancaster, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Precision Biopsy, LLC was formed in partnership with Allied Minds to develop and commercialize novel technology for the accurate diagnosis of prostate cancer. The company’s diagnostic technology uses advanced spectroscopy imaging techniques in combination with tissue biopsy. For the first time, this unique ability will eliminate random prostate biopsies that are subject to sampling errors and can lead to inaccurate grading and staging of the disease. The scientific founders, professors Priya Werahara and John Daily of the University of Colorado, have long studied the morphology of cancer tissue. Combining their knowledge of advanced spectroscopy techniques has resulted in the ability to image the precise location of cancer in the prostate.
As the intraoperative imaging expert, IMRIS, Deerfield Imaging measurably improves patient outcomes through planning, product integration and clinical workflow to give surgeons access to diagnostic quality scans in operating room suites. The IMRIS Surgical Theatre, which uniquely transport MR and CT scanners to the patient using ceiling-mounted rails and incorporate other IMRIS imaging technology, are sold globally to hospitals that deliver clinical services to patients in neurosurgical, spinal, interventional and orthopedic markets.
Accelmed is an investment firm focused on value creation for medical device companies and technologies. Accelmed was founded in 2009 by Mori Arkin and Uri Geiger and invests in small and mid-cap private and public companies.
AccessOne is a leading provider of flexible, co-branded patient financing solutions. Founded by providers, our solution provides a consumer-focused experience which drives high patient satisfaction for our clients. We have helped over one million consumers afford out-of-pocket medical expenses for health systems nationwide. We offer the most comprehensive platform in the industry with funding models that help more providers and programs that reach more patients. All patients qualify for our program with no credit reporting or negative outcomes.